This review study summarizes research published between 1990 and 2021 on the effectiveness of cannabinoid products at relieving gynecological pain. It was published in the journal Obstetrics and Gynecology in February 2022.
The studies the authors evaluated included nonpregnant adult women who used cannabinoids for gynecologic pain caused by chronic pelvic pain, vulvodynia, endometriosis, interstitial cystitis, and cancer malignancy.
"Survey data showed that most women reported that cannabis improved pain from numerous gynecologic conditions. Cohort studies and an RCT (randomized controlled trial) using PEA-combination medications reported pain reduction. However, interpretation of the studies is limited due to varying cannabis formulations, delivery methods, and dosages that preclude a definitive statement about cannabis for gynecologic pain relief."
The last sentence is very true. While there are many studies showing cannabinoid medicines are effective for various conditions, including pain, they focus little attention on specific active ingredients, dosages, and administration methods.
So the patient is left with the positive knowledge that cannabinoid medicines are likely to help, but determining the best types and dosages is basically still an individual trial and error process. That is one reason we started our research project. If you have determined a cannabinoid product that works well for you, please take our 3-minute anonymous survey and share your happiness and knowledge.
The abstract to this paper is here from Obstetrics and Gynecology.